Analyte Health Partners with IQuity To Make Innovative Tests Available

Partnership Expands Access to Cutting-Edge Diagnostic Tests For Multiple Sclerosis, Digestive Disorders, and Fibromyalgia

News provided by

Analyte Health, Inc.

Jan 04, 2018, 02:32 ET

CHICAGO, Jan. 4, 2018 /PRNewswire/ -- Analyte Health, the leading platform connecting patients to diagnostic services, announced today that they have partnered with IQuity, Inc., to make available that organization's innovative diagnostic tests to qualified patients.

Through the partnership, qualified patients will immediately be able to access IQuity's unique, patented diagnostic test, IsolateMS™, to assist their providers in determining whether they might be suffering from multiple sclerosis. The IsolateMS test is just one of the tests that will be made available via Analyte Health's "Health Test Express" website (www.healthtestexpress.com).

"Analyte Health is the leading independent company helping consumers better manage their health through increased access to and understanding of lab diagnostic information. We're excited that more patients can now benefit from IQuity's cutting edge science," said Analyte Health CEO Kevin Weinstein.

IQuity's breakthrough RNA analytic process, IQIsolate™, gives providers a new tool to confirm a suspected autoimmune diagnosis with accuracy greater than 90% and help patients at the earliest sign of symptoms.

IQuity's CEO, Chase Spurlock, PhD, also noted that "As we launched the IsolateMS test, we were looking for clinically appropriate ways to make the test widely available to patients. In addition to our efforts working directly with leading, traditional physician groups, we actively sought out other innovative partners to raise awareness directly with patients. Analyte Health's unique combination of capabilities is the perfect way to introduce our tests to a broader audience. Our mission is to help as many as patients as possible, and Analyte Health offers us the chance to do just that."

In addition to the IsolateMS™ test, Analyte Health and IQuity expect to make available the IsolateIBS-IBD™ test which distinguishes irritable bowel syndrome and inflammatory bowel disease (Crohn's and ulcerative colitis), and the IsolateFibromyalgia™ test. Both tests are expected to be made available via Health Test Express in the first quarter of 2018.

Analyte Health has partnered with several leading, innovative CLIA-certified laboratories to perform lab test analyses and partners with Analyte Physicians Group to offer a full suite of medical services to patients, including providing test recommendations and review of orders, telehealth consultations, treatment and linkage to care.

About IQuity
IQuity is a data science company that uses genomics and proprietary healthcare data to detect and monitor chronic diseases. The company's initial product offerings include its RNA-based Isolate™ tests developed using proprietary machine learning algorithms capable of 'ruling in' or 'ruling out' specific diseases. The accuracy of these methods at the earliest onset of symptoms exceeds 90% and offers providers the ability to shorten the diagnostic process. IQuity will perform the tests in its CLIA-certified laboratory in Nashville, TN.

About Analyte Health
Analyte Health is the leading national company empowering patients to acquire and understand healthcare diagnostic information as conveniently, confidentially, and cost effectively as possible. By combining a national network of patient diagnostic service centers, at-home collection kits, a family of online digital assets, and a national telehealth footprint, Analyte Health is helping thousands of consumers every week, and has delivered more than 2.2 million test results since its inception. Analyte Health works with pharmaceutical companies, telehealth providers, diagnostic companies and other healthcare stakeholders to drive clinical compliance and responsible health awareness for consumers.

Analyte Health
www.analytehealth.com

Media Contact:
Kevin Weinstein
312.771.7883
[email protected]

Company Facts: